NMM
ABBV icon

Naples Money Management’s AbbVie ABBV Stock Holding History

Naples Money Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$69.5K Hold
352
– – 0.06% 77
2024
Q2 		$60K Buy
352
+7
+2% +$1.16K 0.05% 77
2024
Q1 		$62.8K Buy
345
+4
+1% +$689 0.06% 82
2023
Q4 		$52.8K Buy
+341
New +$49.7K 0.05% 90

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Naples Money Management's ABBV Position: Q3 2024 in Review

Naples Money Management held its AbbVie (ABBV) position steady in Q3 2024 at 352 shares worth $69.5K. The position accounts for 0.06% of the portfolio, ranked #77.

Naples Money Management first reported a position in ABBV in Q4 2023 and has held it in 4 quarters since. 3,500 funds tracked by Wall St. Rank hold ABBV as of Q3 2024.

  • Naples Money Management held 352 shares of AbbVie worth $69.5K as of Q3 2024.
  • Naples Money Management left its AbbVie share count unchanged in Q3 2024.
  • AbbVie made up 0.06% of Naples Money Management's portfolio in Q3 2024, its #77 holding.
  • Naples Money Management first reported a position in AbbVie in Q4 2023 and has held it in 4 quarters since.
  • 3,500 funds tracked by Wall St. Rank held AbbVie as of Q3 2024.

Based on Naples Money Management's 13F filing for Q3 2024, filed 12 Nov 2024.